RxDoctor Payments Data

Jonathan Kane

Psychiatry · New York, NYNPI 1184670770

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Boehringer Ingelheim.

$191in general payments, 2019–2025

Across 3 payments — averaging $63.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$191
$1,751,410in research payments, 2019–2025

Across 44 payments — averaging $39,805 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alkermes, Inc.$1.8M

What the payments were for

  • Food & beverage$191100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim3$191

How this compares

$191 in reported general payments places this provider in the 55th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Other psychiatry in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →